SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
3.50
Ask:
4.00
Spread: 0.50 (14.286%)
Market Cap: £1.04m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Trading Statement

8 Jul 2024 08:15

RNS Number : 4832V
Sabien Technology Group PLC
08 July 2024
 

8 July 2024

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

Sabien Technology Group plc

("Sabien" or the "Company" or the "Group")

Trading Update

Sabien (AIM: SNT), a leader in Green Aggregation Strategy, today provides a trading update ahead of the release of its final results for the year ended 30 June 2024.

During the financial year, Sabien has focused on expanding the M2G business, a CO2 mitigation technology for commercial and residential boilers, developing its Sales Agency opportunity with City Oil Field ("COF") and advancing b.grn group Limited ("b.grn"), a Special Purpose Vehicle in which the Company holds a 33.33% stake. This vehicle aims to commercialize COF plastic-to-oil technology.

M2G Business

The M2G Cloud Connect platform enables operators of commercial gas boilers to achieve gas bill savings and CO2 emission reductions of 10%-30%. This technology, when deployed at scale, significantly contributes to the UK's transition to a net-zero economy. M2G installations are quick, offering immediate savings and comprehensive plant analytics, with a typical payback period of less than 12 months.

A recent testimonial from a major Facilities Management partner highlighted the seamless installation and significant energy savings of approximately 30%, enhancing boiler efficiency and proving to be a sustainable, cost-effective solution.

For the year ended 30 June 2024, Sabien has secured orders totalling approximately £0.7m (£1.1m in 2023) and invoiced around £0.6m (£1.1m in 2023). It is notable that the 2023 results included a significant single order of £0.7m from a UK Government customer, whose repeat order for the 2024 financial year has been delayed due to wider political events but is anticipated to be confirmed later in 2024. Excluding this customer, M2G orders have grown by 54% compared to the previous financial year, demonstrating the effectiveness of our expansion strategy. Sabien also boosted its quoting activity with CBRE by 65% this year and in May 2024, signed a Preferred Supplier Agreement with CBRE GWS and CBRE Managed Services Ltd. Multiple blue chip end users were added to the M2G base via Sabien's partner network, all of whom are expected to contribute to future business growth.

Subject to final audit, Sabien expects to recognize revenue of approximately £0.7m for the year ended 30 June 2024 (£1.1m in 2023). As of the year-end, the Company had open orders of approximately £0.06m, deferred revenue of £0.11m, and recurring Cloud revenue of £0.08m, all expected to be recognized in the current financial year, total secured revenue at the start of the year of £0.25m.

During the year, the Board has implemented measures to streamline financial performance, including a 24% reduction in M2G headcount expenses, a 71% reduction in IOT and analytics infrastructure costs, and up to a 60% reduction in the cost of goods through reengineering efforts once the next generation M2G Cloud Connect launches this year. These savings will become evident in the next period.

COF / b.grn

In June 2024, Sabien extended its exclusive Sales Agency Agreement with COF for an additional five years, covering the UK and a region of the United States. This revised agreement includes an increased sales agency fee of up to $1.2m per Regenerative Green Oil ("RGO") module sold and allows for non-exclusive sales agency rights in other countries.

Additionally, Sabien's associate company, b.grn, extended its supply contract with COF for the first Regenerative Green Oil recycling plant outside of Korea by another three years. This extension will facilitate b.grn's progress in waste plastic recycling, with advanced due diligence on selecting a specific site location in the US. Identified UK sites are pending the completion of COF's first production plant in Korea, expected in late 2024, which is essential for securing project finance.

Executive Chairman's Comments

Richard Parris, Executive Chairman, commented:

"The M2G business has achieved significant progress in the year to June 2024, despite the last-minute delay of an expected large recurring order into the next period. Our go-to-market model has been transformed by supply contracts with major property management companies and new prestigious customers validating the M2G proposition. We have streamlined the cost structure of the M2G Team and the technology platform for future success.

The extension of our agreement with COF until June 2029 strengthens Sabien's transition to a Green Aggregation business. We look forward to b.grn building and operating the first COF RGO plant outside of Korea following COF's completion of their domestic plant later this year.

In a show of confidence and commitment to the business, I have pledged £300,000 of non-equity funding from my family office to ensure Sabien has sufficient working capital for the next 12 months without the need for a placement. Details will be finalized in consultation with independent directors and the Company's NOMAD."

The Group anticipates announcing its results for the year ended June 30, 2024, in November 2024.

 

For Further Information:

Sabien Technology Group plc

Richard Parris, Executive Chairman

 

 

 

+44 20 7993 3700

investors@sabien.com 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss / Vivek Bhardwaj 

 

 

+44 203 328 5656

 

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams 

 

 

+44 207 469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFIFLDDFITIIS
Date   Source Headline
10th Mar 20217:00 amRNSCorporate Update - US Subsidiary Established
8th Mar 202110:59 amRNSCorporate Update - Contract win
5th Mar 202112:32 pmRNSNotice of Annual General Meeting
5th Mar 20217:00 amRNSAppointment of Chief Financial Officer
3rd Mar 20214:33 pmRNSHolding(s) in Company
3rd Mar 202110:00 amRNSHolding(s) in Company
1st Mar 20215:06 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSHolding(s) in Company
26th Feb 20215:00 pmRNSTotal Voting Rights
26th Feb 202110:47 amRNSSignificant investment in emerging technology
24th Feb 20212:10 pmRNSHolding(s) in Company
24th Feb 202112:16 pmRNSHolding(s) in Company
23rd Feb 20213:45 pmRNSChange of Registered Office
22nd Feb 202110:35 amRNSResult of General Meeting and Total Voting Rights
12th Feb 20217:00 amRNSHolding(s) in Company
11th Feb 202111:03 amRNSHolding(s) in Company
10th Feb 202111:38 amRNSHolding(s) in Company
3rd Feb 20214:11 pmRNSPlacing and Notice of General Meeting
1st Feb 20217:00 amRNSAppointment of Non-Executive Director
28th Jan 20214:32 pmRNSHolding(s) in Company
28th Jan 20218:14 amRNSHolding(s) in Company
27th Jan 20211:28 pmRNSChange of Substantial Shareholding
27th Jan 20211:26 pmRNSHolding(s) in Company
25th Jan 20217:00 amRNSBoard Changes
20th Jan 20217:30 amRNSRestoration - Sabien Technology Group PLC
20th Jan 20217:00 amRNSWithdrawal from acquisition and other matters
12th Jan 20215:38 pmRNSFrequently asked questions regarding the GM
5th Jan 20217:00 amRNSPosting of Circular and Notice of General Meeting
21st Dec 20205:23 pmRNSHolding(s) in Company
21st Dec 20205:20 pmRNSHolding(s) in Company
2nd Dec 20205:14 pmRNSPosting of Annual Report and Accounts
19th Nov 20207:00 amRNSFinal Results & Update on Proposed Acquisition
5th Nov 20207:00 amRNSChange of Registered Office
2nd Nov 20207:00 amRNSUpdate on Acquisition
14th Sep 20203:30 pmRNSCorporate Update - Contract win
27th Jul 20207:00 amRNSChange of Adviser
27th Jul 20207:00 amRNSUpdate re. Suspension
6th Jul 20207:00 amRNSTrading Update
29th May 202011:15 amRNSManagement Change, Furlough Update
31st Mar 20207:00 amRNSSabien furloughs staff in response to C19 lockdown
20th Mar 20207:00 amRNSHalf-year Report
18th Mar 20207:00 amRNSChange of Adviser
20th Jan 20207:30 amRNSSuspension - Sabien Technology Group plc
20th Jan 20207:30 amRNSStatement re Press Comment
10th Jan 20202:00 pmRNSPrice Monitoring Extension
10th Jan 20201:30 pmRNSIssue of Equity
10th Jan 202010:15 amRNSHolding(s) in Company
8th Jan 20201:15 pmRNSResult of Meeting
19th Dec 201912:30 pmRNSApplication for admission
17th Dec 20194:35 pmRNSNotice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.